Find uplifting stories about heroes, innovations, and solutions
36 results for "glp-1 drugs"
NIH researchers have discovered why popular weight loss drugs like Ozempic eventually stop working as well, and they've found a potential way to extend their effectiveness. The breakthrough could help millions push past frustrating plateaus.
NIH researchers discovered why popular GLP-1 medications like Ozempic eventually stop working as well, and they found a possible solution. The breakthrough could help millions push past frustrating weight loss plateaus.
A five-year study of over 12,000 patients shows that GLP-1 drugs, commonly used for diabetes and weight loss, significantly reduced the spread of four major cancer types. The findings offer new hope for cancer patients, though experts urge caution before prescribing the medications specifically for cancer treatment.
Scientists discovered that popular weight loss medications like Wegovy might one day treat arthritis by fighting inflammation directly inside joints. This breakthrough could transform how millions manage painful joint conditions.
Diabetes medications like Ozempic and Wegovy may help stop cancer from spreading, according to groundbreaking research tracking over 10,000 cancer patients. The study found these drugs reduced the risk of cancer progression by up to 50% for certain tumor types.
Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
The diabetes and weight-loss medication semaglutide (Ozempic/Wegovy) just proved effective at treating alcohol-use disorder in a major clinical trial. Millions struggling with problem drinking now have a new treatment option their doctors already know how to prescribe.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction. The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.
Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial. This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.
Ozempic and similar medications may heal arthritis, liver disease, and more by resetting the immune system, not just through weight loss. Scientists are discovering these drugs work throughout the body to reduce harmful inflammation while keeping infection-fighting power strong.
Early research suggests GLP-1 drugs like Ozempic might help treat endometriosis, offering hope to millions who struggle with limited treatment options. Women are already reporting symptom improvements on social media.
Scientists discovered a naturally occurring hormone that triggers weight loss by speeding up metabolism instead of reducing appetite. Early studies show the hormone FGF21 works differently than popular GLP-1 drugs, offering new hope for obesity treatment.
New research reveals that GLP-1 medications like Wegovy improve heart and liver health even in patients who don't lose weight. The discovery could help millions more people access these life-changing drugs.
New research shows popular weight loss drugs like Wegovy help prevent heart attacks and heal liver disease even in people who don't lose pounds. This discovery could change how millions access life-saving treatment.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
A daily pill helped patients lose 16% of their body weight in 44 weeks, outperforming other oral medications in development. The breakthrough could make obesity treatment more accessible to millions who avoid injections.
A groundbreaking VA study found that GLP-1 medications like Ozempic may reduce substance use disorders across alcohol, opioids, nicotine, and other drugs. For veterans battling addiction alongside diabetes, these findings could change everything.
A new class of medications is transforming obesity treatment by working with the body's hunger signals rather than against them, helping patients lose up to 30% of their body weight. These GLP-1 drugs are proving that obesity has deep biological roots beyond willpower alone.
Showing 20 of 36